ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
17.18
-0.50 (-2.83%)
At close: Aug 1, 2025, 4:00 PM
17.17
-0.01 (-0.06%)
After-hours: Aug 1, 2025, 7:51 PM EDT

R1 RCM Stock Forecast

Stock Price Forecast

The 4 analysts that cover R1 RCM stock have a consensus rating of "Strong Buy" and an average price target of $28.75, which forecasts a 67.35% increase in the stock price over the next year. The lowest target is $27 and the highest is $30.

Price Target: $28.75 (+67.35%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$27$28.75$30$30
Change+57.16%+67.35%+74.62%+74.62%
* Price targets were last updated on Mar 7, 2025.

Analyst Ratings

The average analyst rating for R1 RCM stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111111
Buy444443
Hold000000
Sell000000
Strong Sell000000
Total555554

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Scotiabank
Scotiabank
Buy
Initiates
$30
BuyInitiates$30+74.62%Mar 7, 2025
Raymond James
Raymond James
Strong Buy
Maintains
$26$28
Strong BuyMaintains$26$28+62.98%Jan 14, 2025
Leerink Partners
Leerink Partners
Buy
Maintains
$26$27
BuyMaintains$26$27+57.16%Jan 13, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$30
BuyReiterates$30+74.62%Oct 8, 2024
Leerink Partners
Leerink Partners
Buy
Maintains
$21$25
BuyMaintains$21$25+45.52%Sep 20, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
81.12M
from 89.15M
Decreased by -9.01%
Revenue Next Year
219.54M
from 81.12M
Increased by 170.64%
EPS This Year
-1.50
from 0.08
EPS Next Year
-0.67
from -1.50
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
17.84M5.51M1.32M30.00K89.15M81.12M219.54M368.60M
Revenue Growth
--69.13%-76.10%-97.72%297,063.33%-9.01%170.64%67.90%
EPS
-0.05-0.70-0.87-0.570.08-1.50-0.670.34
EPS Growth
--------
Forward PE
-------50.03
No. Analysts
-----888
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High99.0M260.8M487.2M
Avg81.1M219.5M368.6M
Low54.5M115.3M190.4M

Revenue Growth

Revenue Growth20252026202720282029
High
11.0%
221.5%
121.9%
Avg
-9.0%
170.6%
67.9%
Low
-38.9%
42.1%
-13.3%

EPS Forecast

EPS20252026202720282029
High-1.370.010.86
Avg-1.50-0.670.34
Low-1.59-1.19-0.49

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.